Medical Editor: John P. Cunha, DO, FACOEP
Aerobid and Aerobid M (flunisolide) is an anti-inflammatory steroid and is indicated in the maintenance treatment of asthma as prophylactic therapy and is also indicated for asthma patients who require systemic corticosteroid administration. Aerobid is not indicated for the relief of acute bronchospasm. Aerobid is available in generic from. Common side effects of Aerobid and Aerobid M include weakness, tired feeling, nausea, diarrhea, upset stomach, headache, dizziness, dryness in your mouth/nose/throat, white patches or sores inside your mouth or on your lips, stuffy nose, sinus pain, sore throat, cough, or hoarseness or deepened voice.
The Aerobid Inhaler System is for oral inhalation only. Adults the recommended starting dose is 2 inhalations twice daily, morning and evening, for a total dose of 1 mg. The maximum daily dose should not exceed 4 inhalations twice a day for a total daily dose of 2 mg. For children and adolescents 6-15 years of age, two inhalations may be administered twice daily for a total daily dose of 1 mg. Insufficient information is available to warrant use in children under age 6. Aerobid and Aerobid M may interact with other drugs. Tell your doctor all medications and supplements you use. Aerobid should be used during pregnancy only if the benefit justifies the risk to the fetus. It is unknown if Aerobid passes into breast milk. Consult your doctor before breastfeeding.
Our Aerobid and Aerobid M (flunisolide) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:
- weakness, tired feeling, nausea, loss of appetite, weight loss;
- fast or pounding heartbeats, pain or fluttering in your chest;
- wheezing or breathing problems after using this medication;
- skin rash, bruising, severe tingling, numbness, pain, muscle weakness;
- changes in the shape or location of body fat (especially in your arms, legs, face, neck, breasts, and waist);
- worsening asthma symptoms.
Less serious side effects may include:
- nausea, diarrhea, upset stomach;
- headache, dizziness;
- dryness in your mouth, nose, or throat;
- white patches or sores inside your mouth or on your lips;
- stuffy nose, sinus pain, sore throat, cough; or
- hoarseness or deepened voice.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Aerobid (Flunisolide Inhaler)
Adverse events reported in controlled clinical trials and long-term open studies in 514 patients treated with AEROBID (flunisolide) are described below. Of those patients, 463 were treated for 3 months or longer, 407 for 6 months or longer, 287 for 1 year or longer and 122 for 2 years or longer.
Musculoskeletal reactions were reported in 35% of steroid-dependent patients in whom the dose of oral steroid was being tapered. This is a well-known effect of steroid withdrawal.
Incidence 10% or greater:
Gastrointestinal: diarrhea (10%), nausea and/or vomiting (25%), upset
General: flu (10%)
Mouth and Throat: sore throat (20%)
Nervous System: headache (25%)
Respiratory: cold symptoms (15%), nasal congestion (15%), upper respiratory infection (25%)
Special Senses: unpleasant taste (10%)
Gastrointestinal: abdominal pain, heartburn
General: chest pain, decreased appetite, edema, fever
Mouth and Throat: Candida infection
Nervous System: dizziness, irritability, nervousness, shakiness
Reproductive: menstrual disturbances
Respiratory: chest congestion, cough* hoarseness, rhinitis, runny nose, sinus congestion sinus drainage, sinus infection, sinusitis, sneezing, sputum, wheezing*
Skin: eczema, itching (pruritus), rash
Special Senses: ear infection, loss of smell or taste
General: chills, increased appetite and weight gain, malaise, peripheral
edema, sweating, weakness
Cardiovascular: hypertension, tachycardia
Gastrointestinal: constipation, dyspepsia, gas
Hemic/Lymph: capillary fragility, enlarged lymph nodes
Mouth and Throat: dry throat, glossitis, mouth irritation, pharyngitis, phlegm, throat irritation
Nervous System: anxiety, depression, faintness, fatigue, hyperactivity, hypoactivity insomnia, moodiness, numbness, vertigo
Respiratory: bronchitis, chest tightness* dyspnea, epistaxis, head stuffiness, laryngitis, nasal irritation, pleurisy, pneumonia, sinus discomfort
Skin: acne, hives or urticaria
Special Senses: blurred vision, earache, eye discomfort, eye infection
Incidence less than 1%, judged by investigators as possibly or probably drug related:
abdominal fullness, shortness of breath.
*The incidences as shown of cough, wheezing, and chest tightness were judged by investigators to be possibly or probably drug related. In placebo-controlled trials, the overall incidences of these adverse events (regardless of investigators'judgement of drug relationship) were similar for drug and placebo-treated groups. They may be related to the vehicle or delivery system.
Read the entire FDA prescribing information for Aerobid (Flunisolide Inhaler)
© Aerobid Patient Information is supplied by Cerner Multum, Inc. and Aerobid Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.